Select country

Latest from Clinigen

Investor Relations

Investment case

WHAT IS OUR INVESTMENT CASE?

In becoming the trusted global leader in access to medicines, the Group has consistently delivered healthy financial performances and returns. Read more about our Investment Case by clicking on the link below.

View our Investment Case
Visit our Investor section for more
Video: Clinigen Group

The Clinigen Solution to Clinical Trial Closure

This is what a Managed Access Program looks like with Clinigen - ethical, compliant and patient focused.

Play video
Our mission is simple

Right medicine.
Right patient.
Right time.

Our mission

Clinigen’s mission is to deliver the right medicine to the right patient at the right time, to improve the quality of people’s lives around the world. There are only three ways for a patient to ethically access a medicine: through a clinical trial, unlicensed or commercial route and we are the only company to globally manage access across all three routes.

Our mission
>800

global team of experts across 13 locations

9.5m

units shipped in the last 3 years

+6,000

pharmacists and 250 pharmaceutical company partnerships

130

local knowledge in 130 countries across the world

Who we are

Trusted global
leader

Investors

Clinigen is a rapidly-growing specialty pharmaceutical and services company with a unique business model dedicated to delivering the right medicine to the right patient at the right time to improve the quality of people’s lives around the world.

Investors